- Home
- BYFC vs MNOV Comparison
BYFC vs MNOV Comparison
Compare BYFC & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYFC
- MNOV
- Stock Information
- Founded
- BYFC 1946
- MNOV 2000
- Country
- BYFC United States
- MNOV United States
- Employees
- BYFC N/A
- MNOV N/A
- Industry
- BYFC Savings Institutions
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- BYFC Finance
- MNOV Health Care
- Exchange
- BYFC Nasdaq
- MNOV Nasdaq
- Market Cap
- BYFC 70.3M
- MNOV 68.2M
- IPO Year
- BYFC 1996
- MNOV 2005
- Fundamental
- Price
- BYFC $7.31
- MNOV $1.32
- Analyst Decision
- BYFC
- MNOV Strong Buy
- Analyst Count
- BYFC 0
- MNOV 2
- Target Price
- BYFC N/A
- MNOV $7.00
- AVG Volume (30 Days)
- BYFC 5.9K
- MNOV 35.7K
- Earning Date
- BYFC 07-31-2025
- MNOV 08-14-2025
- Dividend Yield
- BYFC N/A
- MNOV N/A
- EPS Growth
- BYFC N/A
- MNOV N/A
- EPS
- BYFC N/A
- MNOV N/A
- Revenue
- BYFC $33,412,000.00
- MNOV $134,599.00
- Revenue This Year
- BYFC N/A
- MNOV N/A
- Revenue Next Year
- BYFC N/A
- MNOV N/A
- P/E Ratio
- BYFC N/A
- MNOV N/A
- Revenue Growth
- BYFC N/A
- MNOV N/A
- 52 Week Low
- BYFC $5.71
- MNOV $1.13
- 52 Week High
- BYFC $9.46
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- BYFC 37.34
- MNOV 53.19
- Support Level
- BYFC $7.26
- MNOV $1.29
- Resistance Level
- BYFC $8.20
- MNOV $1.40
- Average True Range (ATR)
- BYFC 0.10
- MNOV 0.04
- MACD
- BYFC -0.10
- MNOV -0.00
- Stochastic Oscillator
- BYFC 5.32
- MNOV 60.00
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.